Co-Authors
This is a "connection" page, showing publications co-authored by Jane O'Halloran and Philip Mudd.
Connection Strength
0.991
-
Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19. J Immunol. 2021 09 01; 207(5):1229-1238.
Score: 0.240
-
SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response. Front Immunol. 2020; 11:618402.
Score: 0.231
-
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci Adv. 2020 12; 6(50).
Score: 0.229
-
Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med. 2021 08 17; 2(8):100369.
Score: 0.060
-
Asthma in patients with suspected and diagnosed coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021 05; 126(5):535-541.e2.
Score: 0.058
-
Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. 2021 02 22; 6(4).
Score: 0.058
-
Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 Receptor Blocker. Crit Care Explor. 2021 Feb; 3(2):e0343.
Score: 0.058
-
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int J Infect Dis. 2021 Feb; 103:25-32.
Score: 0.057